Related Experiment Video
Updated: Jun 24, 2026

18:25
Live Imaging Assay for Assessing the Roles of Ca2+ and Sphingomyelinase in the Repair of Pore-forming Toxin Wounds
Published on: August 25, 2013
Acid sphingomyelinase activity triggers microparticle release from glial cells
Fabio Bianco1, Cristiana Perrotta, Luisa Novellino
1CNR Institute of Neuroscience and Department of Medical Pharmacology, University of Milano, Milano, Italy.
The EMBO Journal
|March 21, 2009
Summary
Glial cells, including astrocytes, release microparticles containing IL-1beta upon ATP stimulation. This shedding is dependent on acid sphingomyelinase activation and the p38 MAPK pathway, offering new therapeutic targets for neuroinflammation.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the central nervous system's immune cells, release microparticles containing IL-1beta after ATP stimulation.
- These microparticles play a role in central nervous system inflammatory events.
Purpose of the Study:
- To investigate microparticle release from astrocytes and elucidate the underlying shedding mechanism.
- To identify key molecular players involved in ATP-induced microparticle formation and IL-1beta release from glial cells.
Main Methods:
- Utilized glial cell cultures, including those from acid sphingomyelinase knockout mice.
- Stimulated cells with ATP and assessed microparticle shedding and IL-1beta release.
- Investigated the role of acid sphingomyelinase activation and the p38 MAPK cascade using specific inhibitors.
Main Results:
- Astrocytes, similar to microglia, release microparticles upon ATP stimulation via the P2X7 receptor.
- ATP-induced microparticle shedding and IL-1beta release are dependent on acid sphingomyelinase activation and its translocation to the plasma membrane.
- Inhibition of acid sphingomyelinase or the p38 MAPK pathway significantly reduces microparticle formation and IL-1beta release.
Conclusions:
- Acid sphingomyelinase activation is both necessary and sufficient for microparticle release from glial cells.
- The p38 MAPK cascade is crucial for acid sphingomyelinase activation, microparticle shedding, and IL-1beta release.
- These findings offer novel therapeutic strategies for treating neuroinflammatory diseases by targeting microparticle formation.

